
Large language models are sure-footed at supplying answers, but what happens in medical contexts when that certainty can be a liability?

Large language models are sure-footed at supplying answers, but what happens in medical contexts when that certainty can be a liability?

As a wave of blockbuster biologics face loss of exclusivity, some hope that there may be a “second phase” of biosimilar adoption.

Provider networks are a fundamental part of U.S. health insurance. But an increasing number of self-insured employers are offering low-premium health plans without networks, and the CMS is working toward having such plans available on the ACA marketplaces.

The premiums may be low but the deductibles are high. More people are enrolling in ACA bronze plans because of the expiration of COVID-19 enhanced subsidies. And the Trump administration is taking steps to encourage enrollment in high-deductible, low-premium catastrophic coverage.